Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MXL vs GSK✓SelectedUSD · GSKMXL vs GSK performance historyLatest closeAs of-6.83%11/16
Stock and ETF performance explorer

MXL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+177.9%
GSK return
+198.3%
Excess return
-20.4%
Maximum drawdown
-88.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-6.8%-0.1%-6.8%-6.8%
7D-7.0%-1.3%-5.7%-6.7%
30D-27.1%+2.7%-29.9%-28.1%
3M-38.7%+2.7%-41.5%-40.1%
6M-43.7%+3.3%-47.0%-45.8%
YTD+198.2%+6.5%+191.7%+176.1%
1Y+273.9%+10.7%+263.2%+239.4%
3Y+195.8%+64.4%+131.4%+103.3%
5Y-27.7%+46.7%-74.4%-48.6%
10Y+145.0%+109.4%+35.7%+33.0%
All+177.9%+198.3%-20.4%+0.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling